Eli Lilly and Co
XBER:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XBER:LLY
|
US |
|
D
|
DongBang Medical Co Ltd
KOSDAQ:240550
|
KR |
|
S
|
SHS Holdings Ltd
SGX:566
|
SG |
Intrinsic Value
The
intrinsic value for
Eli Lilly and Co (LLY)
under the Base Case is
359.6
EUR.
Compared with the current market price of 913.5 EUR, the stock appears
Overvalued by 61%.
Both DCF and multiples point to overvaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Eli Lilly and Co.
Fundamental Analysis
Revenue & Expenses Breakdown
Eli Lilly and Co
Earnings Waterfall
Eli Lilly and Co
The
intrinsic value for
Eli Lilly and Co (LLY)
under the Base Case is
359.6
EUR.
Compared with the current market price of 913.5 EUR, the stock appears Overvalued by 61%.